30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

HAYDEN DONALD J JR

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 152% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
HAYDEN DONALD J JR's trades of Theseus Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-03 2022-12-30
B Purchase
99,969 +36.8%
314.04
US$4,494,809 		99,969 +36.8% 314.04 US$4,494,809
2023-01-03 2022-12-29
B Purchase
39,854 -38.5%
199.85
US$1,479,349 		39,854 -38.5% 199.85 US$1,479,349
2020-02-12 2020-02-10
US Regenxbio Inc (RGNX)
PlS Planned sale
77,552 -47.3%
93.88
US$2,422,638 		77,552 -47.3% 93.88 US$2,422,638
2020-02-07 2020-02-05
US Regenxbio Inc (RGNX)
PlS Planned sale
2,000 -100.0%
50.00
US$100,000 		2,000 -100.0% 50.00 US$100,000
2020-01-21 2020-01-17
US Regenxbio Inc (RGNX)
PlS Planned sale
3,200 -100.0%
50.01
US$160,032 		3,200 -100.0% 50.01 US$160,032
2020-01-16 2020-01-14
US Regenxbio Inc (RGNX)
PlS Planned sale
30,000 -100.0%
45.60
US$1,368,000 		30,000 -100.0% 45.60 US$1,368,000
2019-04-11 2019-04-09
US Insmed Inc (INSM)
PlS Planned sale
6,286 -9.2%
32.99
US$207,375 		6,286 -9.2% 32.99 US$207,375
2019-02-26 2019-02-22
US Insmed Inc (INSM)
PlS Planned sale
14,900 -19.3%
28.08
US$418,392 		14,900 -19.3% 28.08 US$418,392
2019-02-27 2019-02-15
US Insmed Inc (INSM)
PlS Planned sale
100 -0.2%
27.90
US$2,790 		100 -0.2% 27.90 US$2,790